dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

This website has run out of funding so feel free to contribute if you can afford it (see footer)

Author Topic: Phenibut (β-Phenyl-GABA): A Tranquilizer and Nootropic Drug (technical)  (Read 2348 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6502
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:September 18, 2021, 05:24:31 AM
  • Deeply Confused Learner
  • Profession: IT Engineer
very thorough study - if anyone is interested in Phenibut then this is the stuff to read.

http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2001.tb00211.x/pdf

ABSTRACT

Phenibut (â-phenyl-ã-aminobutyric acid HCl) is a neuropsychotropic drug that was discovered
and introduced into clinical practice in Russia in the 1960s. It has anxiolytic and
nootropic (cognition enhancing) effects. It acts as a GABA-mimetic, primarily at GABAB
and, to some extent, at GABAA receptors. It also stimulates dopamine receptors and antagonizes
â-phenethylamine (PEA), a putative endogenous anxiogenic. The psychopharmacological
activity of phenibut is similar to that of baclofen, a p-Cl-derivative of phenibut.
This article reviews the structure-activity relationship of phenibut and its derivatives. Emphasis
is placed on the importance of the position of the phenyl ring, the role of the carboxyl
group, and the activity of optical isomers. Comparison of phenibut with piracetam
and diazepam reveals similarities and differences in their pharmacological and clinical effects.
Phenibut is widely used in Russia to relieve tension, anxiety, and fear, to improve
sleep in psychosomatic or neurotic patients; as well as a pre- or post-operative medication.
It is also used in the therapy of disorders characterized by asthenia and depression, as well
as in post-traumatic stress, stuttering and vestibular disorders.
« Last Edit: August 09, 2017, 07:57:51 AM by chipper »
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
I do not condone or support any illegal activities. All information is for theoretical discussion and wonder.
All activities discussed are considered fictional and hypothetical. Information of all discussion has been derived from online research and in the spirit of personal Freedom.

Tags:
 

Related Topics

  Subject / Started by Replies Last post
2 Replies
3302 Views
Last post July 12, 2015, 11:15:23 AM
by Narkotikon
2 Replies
4175 Views
Last post August 29, 2015, 01:20:39 PM
by Narkotikon
9 Replies
5349 Views
Last post November 30, 2019, 06:00:55 AM
by Chip
11 Replies
7114 Views
Last post December 27, 2015, 07:49:48 PM
by sk8phaze
4 Replies
4042 Views
Last post December 19, 2016, 07:24:07 AM
by milky
0 Replies
2019 Views
Last post August 19, 2017, 05:35:17 AM
by Chip
0 Replies
2033 Views
Last post August 19, 2017, 01:32:25 PM
by Chip
3 Replies
3104 Views
Last post March 14, 2018, 04:58:20 PM
by limerence
0 Replies
1611 Views
Last post December 30, 2018, 10:03:59 PM
by Chip
0 Replies
1340 Views
Last post August 27, 2019, 07:29:53 PM
by Chip


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal